LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,939 | -7.3% | 1,017 | +11.5% | 0.00% | 0.0% |
| Q2 2023 | $65,755 | +6.5% | 912 | +8.7% | 0.00% | 0.0% |
| Q1 2023 | $61,717 | -1.3% | 839 | -10.4% | 0.00% | 0.0% |
| Q4 2022 | $62,525 | -16.3% | 936 | +7.8% | 0.00% | -25.0% |
| Q3 2022 | $74,743 | -15.9% | 868 | -12.9% | 0.00% | 0.0% |
| Q2 2022 | $88,863 | -20.7% | 996 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $112,040 | -82.1% | 996 | -75.4% | 0.00% | -50.0% |
| Q4 2021 | $625,409 | +10.9% | 4,049 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $564,107 | -37.2% | 4,049 | -40.9% | 0.01% | -38.5% |
| Q2 2021 | $898,783 | -10.3% | 6,851 | +4.2% | 0.01% | -13.3% |
| Q1 2021 | $1,002,511 | +43.5% | 6,576 | -6.4% | 0.02% | +50.0% |
| Q4 2020 | $698,437 | +3.4% | 7,023 | -0.9% | 0.01% | -16.7% |
| Q3 2020 | $675,723 | -16.5% | 7,089 | -2.0% | 0.01% | -14.3% |
| Q2 2020 | $809,458 | +20.8% | 7,237 | -21.5% | 0.01% | 0.0% |
| Q1 2020 | $670,042 | -33.8% | 9,214 | -5.1% | 0.01% | -17.6% |
| Q4 2019 | $1,012,552 | -6.4% | 9,709 | -10.7% | 0.02% | -5.6% |
| Q3 2019 | $1,082,199 | -19.7% | 10,872 | -7.9% | 0.02% | -21.7% |
| Q2 2019 | $1,347,541 | -10.9% | 11,805 | -1.8% | 0.02% | -14.8% |
| Q1 2019 | $1,511,788 | -9.9% | 12,026 | -2.8% | 0.03% | -20.6% |
| Q4 2018 | $1,678,338 | -9.4% | 12,368 | +83.2% | 0.03% | +3.0% |
| Q3 2018 | $1,853,356 | -99.9% | 6,752 | 0.0% | 0.03% | +43.5% |
| Q2 2018 | $1,398,811,000 | +33.3% | 6,752 | +6.3% | 0.02% | +53.3% |
| Q1 2018 | $1,049,096,000 | +116079.0% | 6,352 | -3.6% | 0.02% | +25.0% |
| Q4 2017 | $903,000 | -51.1% | 6,591 | -51.4% | 0.01% | 0.0% |
| Q3 2017 | $1,845,000 | +12.2% | 13,548 | 0.0% | 0.01% | +9.1% |
| Q2 2017 | $1,645,000 | +14.7% | 13,548 | 0.0% | 0.01% | +10.0% |
| Q1 2017 | $1,434,000 | +4.1% | 13,548 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $1,377,000 | -0.4% | 13,548 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $1,383,000 | -16.1% | 13,548 | -2.0% | 0.01% | -16.7% |
| Q2 2016 | $1,648,000 | +16.5% | 13,818 | +4.6% | 0.01% | +9.1% |
| Q1 2016 | $1,415,000 | +6.2% | 13,214 | +7.6% | 0.01% | +10.0% |
| Q4 2015 | $1,332,000 | +26.6% | 12,281 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $1,052,000 | -15.1% | 12,281 | 0.0% | 0.01% | -11.1% |
| Q2 2015 | $1,239,000 | +2.0% | 12,281 | -22.1% | 0.01% | 0.0% |
| Q1 2015 | $1,215,000 | +45.0% | 15,756 | 0.0% | 0.01% | +50.0% |
| Q4 2014 | $838,000 | +13.2% | 15,756 | 0.0% | 0.01% | +20.0% |
| Q3 2014 | $740,000 | -24.6% | 15,756 | 0.0% | 0.01% | -28.6% |
| Q2 2014 | $981,000 | -0.3% | 15,756 | +7.7% | 0.01% | 0.0% |
| Q1 2014 | $984,000 | +26.5% | 14,626 | -1.1% | 0.01% | +40.0% |
| Q4 2013 | $778,000 | +23.3% | 14,783 | +1.3% | 0.01% | 0.0% |
| Q3 2013 | $631,000 | +23.2% | 14,587 | +6.7% | 0.01% | +25.0% |
| Q2 2013 | $512,000 | – | 13,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |